Ex Vivo and in Vivo Effects of Isofagomine on Acid β-Glucosidase Variants and Substrate Levels in Gaucher Disease
Open Access
- 1 February 2012
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (6) , 4275-4287
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Isofagomine In Vivo Effects in a Neuronopathic Gaucher Disease MousePLOS ONE, 2011
- Acid β‐glucosidase mutants linked to gaucher disease, parkinson disease, and lewy body dementia alter α‐synuclein processingAnnals of Neurology, 2011
- X-ray and Biochemical Analysis of N370S Mutant Human Acid β-GlucosidaseJournal of Biological Chemistry, 2011
- Comparative Therapeutic Effects of Velaglucerase Alfa and Imiglucerase in a Gaucher Disease Mouse ModelPLOS ONE, 2010
- The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of β‐glucosidaseThe FEBS Journal, 2010
- Effects of pH and Iminosugar Pharmacological Chaperones on Lysosomal Glycosidase Structure and StabilityBiochemistry, 2009
- Conditional expression of human acid β-glucosidase improves the visceral phenotype in a Gaucher disease mouse modelJournal of Lipid Research, 2006
- The iminosugar isofagomine increases the activity of N370S mutant acid β-glucosidase in Gaucher fibroblasts by several mechanismsProceedings of the National Academy of Sciences, 2006
- A Large Difference in the Thermodynamics of Binding of Isofagomine and 1-Deoxynojirimycin to β-GlucosidaseJournal of the American Chemical Society, 2000
- Analysis and Classification of 304 Mutant Alleles in Patients with Type 1 and Type 3 Gaucher DiseaseThe American Journal of Human Genetics, 2000